Last reviewed · How we verify

NCT05991635

Evaluation of a Gatekeeper Training for Pharmacists

Completed NA Last updated 6 February 2024
What this trial tests

NA trial testing Gatekeeper training (e-learning) in Suicide in 201 participants. Completed in 11 January 2024.

Timeline
12 April 2023
Primary endpoint
11 January 2024
11 January 2024

Quick facts

Lead sponsorUniversity Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment201
Start date12 April 2023
Primary completion11 January 2024
Estimated completion11 January 2024
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Ghent

Who can join

18 and older, any sex, with Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate to what extent a gatekeeper training (e-learning) for pharmacists and PTA is effective in changing the attitudes, knowledge, and self-efficacy. Moreover, it aims to examine how they evaluate the training and whether they were able to apply the learned skills in practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Gatekeeper training (e-learning)

Trials testing the same drug.

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other University Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05991635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing